Patents by Inventor Zuping Xia

Zuping Xia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210276987
    Abstract: The present disclosure describes novel compounds and compositions that reduce nicotine mediated cravings in humans. In embodiments, the novel compounds blocking CYP2A6-meditated nicotine metabolism thereby reducing the need for additional nicotine. Leading to a desirable treatment option in reducing nicotine craving which does not exacerbate the sympathetic response rate caused by the abused substance and which has favorable pharmacodynamics effects.
    Type: Application
    Filed: July 3, 2019
    Publication date: September 9, 2021
    Applicant: Washington State University
    Inventors: Philip Lazarus, Travis Denton, Gang Chen, Pramod Srivastava, Alec Wynd, Zuping Xia, Christy Watson
  • Publication number: 20100137315
    Abstract: The invention relates to compounds, pharmaceutical compositions thereof, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
    Type: Application
    Filed: November 30, 2009
    Publication date: June 3, 2010
    Applicant: APOGEE BIOTECHNOLOGY CORPORATION
    Inventors: Charles D. Smith, Kevin J. French, Zuping Xia
  • Publication number: 20070032531
    Abstract: The invention relates to compounds, pharmaceutical compositions thereof, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease,
    Type: Application
    Filed: August 3, 2006
    Publication date: February 8, 2007
    Applicant: Apogee Biotechnology Corporation
    Inventors: Charles Smith, Kevin French, Zuping Xia